Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2018-04-26 Interim / Quarterly Rep…
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Resultater for 1. kvartal 2018 for Medistim ASA
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive quarterly financial report for Medistim for the first quarter of 2018. It contains detailed financial statements (income statement, balance sheet), operational status updates, market analysis, and shareholder information. It is clearly a substantive financial report rather than a brief announcement or a certification, fitting the definition of an Interim/Quarterly Report (IR). Q1 2018
2018-04-26 Norwegian
Results for the first quarter 2018 for Medistim ASA
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive quarterly financial report for Medistim for the first quarter of 2018. It contains detailed financial statements, including sales, operating profit (EBIT), balance sheet data, and management's analysis of operational performance across different geographic regions (Europe, USA, Asia). It also discusses clinical study results, market trends, and shareholder information. Since it provides substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q1 2018
2018-04-26 English
Resultater for 1. kvartal 2018 for Medistim ASA
Interim / Quarterly Report Classification · 95% confidence The document is a presentation titled 'Medistim ASA First Quarter 2018' dated April 26th, 2018. It contains detailed financial statements (Profit and Loss, Balance Sheet), business segment updates, and strategic outlooks. While it is a presentation, it provides substantive quarterly financial data and analysis, fitting the definition of an Interim/Quarterly Report (IR) rather than just an investor presentation (IP) or a simple announcement. Q1 2018
2018-04-26 Norwegian
Results for the first quarter 2018 for Medistim ASA
Interim / Quarterly Report Classification · 95% confidence The document is a presentation titled 'Medistim ASA First Quarter 2018' dated April 26th, 2018. It contains detailed financial statements (Profit and Loss, Balance Sheet), business segment updates, and strategic outlooks. While it is a presentation, it provides substantive quarterly financial data and analysis, fitting the definition of an Interim/Quarterly Report (IR) rather than just an investor presentation (IP) or a simple announcement. Q1 2018
2018-04-26 English
Resultater for 1. kvartal 2018 for Medistim ASA
Earnings Release Classification · 100% confidence The document text explicitly states 'Resultater for 1. kvartal 2018' (Results for the 1st quarter 2018) and provides key financial metrics (Revenue, EBIT) for that period, along with operational highlights. This content strongly indicates a release of periodic financial results. Since it is a summary of quarterly results, it aligns best with the 'Earnings Release' (ER) definition, which covers initial announcements of periodical financial results (key highlights only). The document is short (685 chars) and presents the highlights directly, not announcing a separate, larger report. Q1 2018
2018-04-26 Norwegian
Results for the first quarter 2018 for Medistim ASA
Earnings Release Classification · 100% confidence The document text explicitly states 'Results for the first quarter 2018' and provides key financial metrics (Sales, Operating profit) for that period, along with operational highlights. This content structure strongly indicates an initial announcement of periodical financial results, which aligns with the Earnings Release (ER) definition. Although it mentions a dividend payment decided by the General Meeting, the primary focus is the quarterly financial performance summary. Given the short length (673 chars) and summary nature, it is an ER, not a comprehensive Interim Report (IR). Q1 2018
2018-04-26 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.